"Over 44 years of expertise in providing multi specialty, one-stop healthcare destination for people with health problems at a affordable cost with the support of high tech facilities."

During the past decade, Bhagwan Mahaveer Jain Heart Centre conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bhagwan Mahaveer Jain Heart Centre" #1 sponsor was "Kowa Research Europe" with 4 trials, followed by "Aqumen Biopharmaceuticals, N.A." with 2 trials sponsored, "Stempeutics Research Pvt Ltd" with 2 trials sponsored, "AtheroGenics" with 1 trials sponsored and "Datascope Corp." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bhagwan Mahaveer Jain Heart Centre" #1 collaborator was "Duke University" with 1 trials as a collaborator, "Flinders Medical Centre" with 1 trials as a collaborator and "Indian Society of Critical Care Medicine" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Bhagwan Mahaveer Jain Heart Centre" are "Dyslipidemia" (4 trials), "Mature Cataracts" (2 trials), "Type II Diabetes Mellitus" (2 trials), "Acute Myocardial Infarction (AMI)" (1 trials) and "Adenoviral Conjunctivitis" (1 trials). Many other conditions were trialed in "Bhagwan Mahaveer Jain Heart Centre" in a lesser frequency.

Most popular intervention types in "Bhagwan Mahaveer Jain Heart Centre" are "Drug" (11 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pitavastatin" (4 trials), "Atorvastatin" (3 trials), "DYME" (2 trials), "Placebo" (2 trials) and "Plasmalyte A" (2 trials). Other intervention names were less common.

The vast majority of trials in "Bhagwan Mahaveer Jain Heart Centre" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Bhagwan Mahaveer Jain Heart Centre". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Bhagwan Mahaveer Jain Heart Centre, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Bhagwan Mahaveer Jain Heart Centre, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".